FAQ
Log In
Monday 23rd April 2018
News
 › 
 › 

New pill stops menstruation

5th January 2007

15092006_young_couple1.jpgThe UK Family Planning Association (FPA) has welcomed a new pill designed to stop women menstruating.

A spokesperson for the FPA said the new pill gave women more choice, adding, "Some [women] do not like the inconvenience of periods."

The new pill, called Lybrel, has been trialled by 2,000 women and was found to stop the periods in half of those who took the drug.  It is the first contraceptive pill designed to completely stop the fertility cycle; current oral contraceptives are taken for 21 days per month allowing a 7-day gap in which a women has her period.  The researchers who led the trial claim to have proven that the new pill is both safe and effective despite reports of irregular bleeding in some of the women.

Although many people believe the female biological rhythm is an essential part of womanhood, some gynaecologists argue that there is no reason why women should continue to suffer the pain, discomfort and emotional disturbance associated with menstruation.  They say that eliminating a woman’s periods is no different than treating the menopause with hormone replacement therapy or impotence with Viagra.

The unlicensed drug is expected to be launched next year.

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: New pill stops menstruation
Author: Sue Knights
Article Id: 1614
Date Added: 5th Jan 2007

Sources

National Library for Health

Recent Related Articles

Newcastle Hospitals appoints new chief executive

Energy drinks ban in the UK

New online therapy tool for depression

Actions

Add to scrapbook
Show Comments
Add comment
Find all related articles

Tags

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2018